Attached files
file | filename |
---|---|
10-K - SPO Global Inc | v178570_10k.htm |
EX-32 - SPO Global Inc | v178570_ex32.htm |
EX-10.18 - SPO Global Inc | v178570_ex10-18.htm |
EX-10.19 - SPO Global Inc | v178570_ex10-19.htm |
EX-10.17 - SPO Global Inc | v178570_ex10-17.htm |
EXHIBIT
31
RULE
13A-14(A) / 15D-14(A) CERTIFICATION
I,
Michael Braunold, certify that:
1.
I have reviewed this Annual Report on Form 10-K for the
year ended December 31, 2009 of SPO Medical Inc.
2.
Based on my knowledge, this annual report does not
contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by
this report;
3.
Based on my knowledge, the financial statements, and
other financial information included in this report, fairly present in all
material respects the financial condition, results of operations and cash flows
of the registrant as of, and for, the period presented in this
report;
4.
I am responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under my supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to me by others within those entities, particularly
during the period in which this report is being prepared;
b)
designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under my supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
c)
evaluated the effectiveness of the registrant’s disclosure controls and
procedures and presented in this report my conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and
d)
disclosed in this report any change in the registrant’s internal
control over financial reporting that occurred during the
registrant’s most recent fiscal quarter (the registrant’s fourth
fiscal quarter in the case of an annual report) that has materially affected, or
is reasonably likely to materially affect, the registrant’s internal control
over financial reporting;
5.
I have disclosed, based on my most recent evaluation
of internal control over financial reporting, to the registrant’s auditors and
the audit committee of registrant's board of directors (or persons fulfilling
the equivalent function):
a)
All significant deficiencies and material weaknesses in
the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record,
process, summarize and report financial information; and
b)
Any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrant’s
internal control over financial reporting.
Date:
March 29, 2010
/s/
Michael Braunold
|
|
Michael
Braunold
|
|
Chief
Executive Officer (Principal Executive Officer and Principal Financial and
Accounting
Officer)
|